Aldeyra Therapeutics Inc (NASDAQ:ALDX)

9.10
Delayed Data
As of Jul 23
 -0.08 / -0.87%
Today’s Change
5.53
Today|||52-Week Range
15.95
+32.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
AssetsCash18.0M47.4M5.3M7.4M
 
 
 
 
 
Short Term Investment Cash-6.6M29.3M-3.1M-4.9M
 
 
 
 
 
Cash & Short Term Investments35.1M93.6M43.1M37.5M
 
 
 
 
 
 
ReceivablesReceivables0.000.0039.0M32.0M
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets1.7M1.2M4.9M3.4M
 
 
 
 
 
Current Assets36.8M94.8M87.0M72.9M
 
 
 
 
 
 
Total AssetsOther Assets43.0K86.6K538.0K492.4K
 
 
 
 
 
Total Assets37.1M95.1M88.1M73.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.4M3.1M4.0M2.8M
 
 
 
 
 
Short Term Debt465.3K0.00221.1K211.7K
 
 
 
 
Accrued Expenses2.6M4.2M4.8M2.4M
 
 
 
 
 
Other Current Liabilities2.6M4.2M4.8M2.4M
 
 
 
 
 
Other Liabilities7.7M8.5M9.5M6.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt882.8K0.00156.8K116.1K
 
 
 
 
Total Liabilities8.5M8.5M9.6M6.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity28.6M86.6M78.5M67.3M
 
 
 
 
 
Total Shareholder Equity28.6M86.6M78.5M67.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding21.0M26.2M26.9M27.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.